A detailed history of Bar Harbor Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Bar Harbor Wealth Management holds 3,669 shares of NVS stock, worth $361,213. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,669
Previous 4,019 8.71%
Holding current value
$361,213
Previous $427,000 1.17%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$106.13 - $120.89 $37,145 - $42,311
-350 Reduced 8.71%
3,669 $422,000
Q2 2024

Jul 17, 2024

SELL
$92.57 - $107.37 $370 - $429
-4 Reduced 0.1%
4,019 $427,000
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $47,920 - $54,560
503 Added 14.29%
4,023 $389,000
Q4 2023

Jan 17, 2024

BUY
$92.27 - $101.54 $28,880 - $31,782
313 Added 9.76%
3,520 $355,000
Q2 2023

Aug 09, 2023

SELL
$92.52 - $104.91 $9,252 - $10,491
-100 Reduced 3.02%
3,207 $323,000
Q4 2022

Jan 19, 2023

BUY
$75.55 - $92.52 $5,364 - $6,568
71 Added 2.19%
3,307 $300,000
Q3 2022

Oct 24, 2022

BUY
$74.61 - $87.26 $3,655 - $4,275
49 Added 1.54%
3,236 $246,000
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $256,617 - $298,781
3,187 New
3,187 $269,000
Q1 2022

Apr 14, 2022

SELL
$80.11 - $90.62 $239,208 - $270,591
-2,986 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$79.7 - $88.13 $7,970 - $8,813
-100 Reduced 3.24%
2,986 $262,000
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $15,701 - $18,266
-192 Reduced 5.86%
3,086 $253,000
Q2 2021

Aug 11, 2021

SELL
$85.24 - $94.15 $14,235 - $15,723
-167 Reduced 4.85%
3,278 $300,000
Q1 2021

May 06, 2021

SELL
$83.5 - $98.47 $5,845 - $6,892
-70 Reduced 1.99%
3,445 $294,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $58,396 - $70,633
-748 Reduced 17.55%
3,515 $332,000
Q3 2020

Nov 02, 2020

SELL
$82.14 - $91.0 $285,436 - $316,225
-3,475 Reduced 44.91%
4,263 $371,000
Q2 2020

Aug 04, 2020

SELL
$80.93 - $91.1 $68,143 - $76,706
-842 Reduced 9.81%
7,738 $676,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $104,026 - $145,742
-1,472 Reduced 14.64%
8,580 $707,000
Q4 2019

Feb 11, 2020

SELL
$84.35 - $95.37 $65,624 - $74,197
-778 Reduced 7.18%
10,052 $952,000
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $23,437 - $25,827
-274 Reduced 2.47%
10,830 $941,000
Q2 2019

Aug 01, 2019

BUY
$75.4 - $92.8 $11,385 - $14,012
151 Added 1.38%
11,104 $1.01 Million
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $30,127 - $34,460
-400 Reduced 3.52%
10,953 $1.05 Million
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $33,515 - $37,319
-455 Reduced 3.85%
11,353 $974,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $21,286 - $24,622
-318 Reduced 2.62%
11,808 $1.02 Million
Q2 2018

Aug 10, 2018

SELL
$64.91 - $73.36 $95,936 - $108,426
-1,478 Reduced 10.86%
12,126 $916,000
Q1 2018

Apr 06, 2018

SELL
$70.39 - $84.15 $168,513 - $201,455
-2,394 Reduced 14.96%
13,604 $1.1 Million
Q4 2017

Jan 17, 2018

SELL
$72.33 - $77.64 $142,707 - $153,183
-1,973 Reduced 10.98%
15,998 $1.34 Million
Q3 2017

Oct 11, 2017

BUY
$74.14 - $77.27 $1.33 Million - $1.39 Million
17,971
17,971 $1.54 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.